At the Crossroads for Intravenous Iron Dosing
- PMID: 32606032
- PMCID: PMC7351009
- DOI: 10.1681/ASN.2020040540
At the Crossroads for Intravenous Iron Dosing
Keywords: anemia; clinical nephrology; dialysis.
Comment in
-
Authors' Reply.J Am Soc Nephrol. 2020 Jul;31(7):1654. doi: 10.1681/ASN.2020050624. Epub 2020 Jun 1. J Am Soc Nephrol. 2020. PMID: 32606033 Free PMC article. No abstract available.
Comment on
-
Intravenous Iron Dosing and Infection Risk in Patients on Hemodialysis: A Prespecified Secondary Analysis of the PIVOTAL Trial.J Am Soc Nephrol. 2020 May;31(5):1118-1127. doi: 10.1681/ASN.2019090972. Epub 2020 Apr 6. J Am Soc Nephrol. 2020. PMID: 32253271 Free PMC article. Clinical Trial.
References
-
- Macdougall IC, White C, Anker SD, Bhandari S, Farrington K, Kalra PA, et al. .; PIVOTAL Investigators and Committees: Intravenous iron in patients undergoing maintenance hemodialysis [published correction appears in N Engl J Med 380: 502, 2019]. N Engl J Med 380: 447–458, 2019. - PubMed
-
- US-DOPPS Practice Monitor: Monthly IV iron dose received (90 day average), categories. National sample, 2020. Available at: https://www.dopps.org/DPM/DPMSlideBrowser.aspx?type=Topic&id=1. Accessed April 28, 2020
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical